Abnormal bone mineral maturation in the chronic uremic state
The Journal of Clinical Investigation
|November 1, 1973
Summary
Chronic kidney disease in rats impairs bone mineral maturation, leading to smaller apatite crystals and increased amorphous mineral content. This bone crystal defect worsens with the progression of chronic renal insufficiency.
Area of Science:
- Bone biology
- Mineral metabolism
- Renal osteodystrophy
Background:
- Chronic uremia affects mineral metabolism and bone health.
- Bone abnormalities are common in patients with chronic kidney disease.
Purpose of the Study:
- To investigate the impact of chronic uremia on bone apatite crystal maturation in rats.
- To determine if the bone crystal maturational defect progresses with increasing severity of chronic renal insufficiency.
Main Methods:
- X-ray diffraction analysis was used to examine bone mineral characteristics.
- Uremic rats with normocalcemia and hyperphosphatemia were compared to age-matched controls.
- Bone samples from rats with varying degrees of chronic renal insufficiency were analyzed.
Main Results:
- Uremic rats exhibited smaller apatite crystals and a higher proportion of X-ray amorphous mineral fraction compared to controls.
- These findings indicate less advanced mineral maturation in the bones of uremic rats.
- A progressive defect in bone crystal maturation was observed with advancing stages of uremia.
Conclusions:
- Chronic uremia, even without acidosis, leads to impaired bone mineral maturation.
- The observed bone crystal maturational defect is directly related to the severity of chronic renal insufficiency.
Related Concept Videos
What is the Skeletal System?
45.7K
Overview
45.7K
Bone Remodeling
34.4K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
34.4K
Osteoclasts in Bone Remodeling
3.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.9K
Bone Disorders
8.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
8.0K
Chronic Kidney Disease I: Introduction
1.4K
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.4K
Chronic Kidney Disease II: Clinical Manifestations
1.1K
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.1K


